Latest Breaking News On - Ricke winningham - Page 1 : comparemela.com

Theravance Biopharma, Inc Reports First Quarter 2024 Financial Results and Provides Business Update

Theravance Biopharma, Inc Reports First Quarter 2024 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRicke winninghamTheravance biopharmaAsia pacificCompany formNational institute of neurological disordersWhile viatris incNeurological instituteDevelopment rd expensesSecurities exchangePrnewswire theravance biopharma incCompany annual report on formTheravance biopharma incChief executiveKey opinion leader ledLatin america

Theravance Biopharma, Inc Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Theravance Biopharma, Inc Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRicke winninghamTheravance biopharmaPrnewswire theravance biopharma incCompany annual report on formMylan irelandDevelopment rd expensesInternational symposiumNeurological instituteSecurities exchangeUs department of justiceTeva pharmaceuticals united states incAccord healthcare incTheravance biopharma incCompany formNational institute of neurological disorders

Revefenacin vs Tiotropium: Treatments Compared in Severe COPD

A phase 4 study compared revefenacin inhalation solution to tiotropium dry powder inhaler for treatment of severe to very severe COPD.

Theravance biopharmaRicke winningham

Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Spiriva handihalerTheravance biopharmaRicke winninghamTheravance biopharma viatrisCompany formSecurities exchangePrnewswire theravance biopharma incViatris incTheravance biopharma incPrescribing informationPatient informationPrivate securities litigation reform actSecurities exchange actBiopharma contact

Theravance Biopharma (TBPH) Appoints Jeremy Grant to its Board

Theravance Biopharma (TBPH) Appoints Jeremy Grant to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Burton malkielRicke winninghamAdam katzExchange commissionTheravance biopharma incTheravance biopharmaSpecial advisorIrenic capital managementTheravance boardGeneral meetingCurrent reportChief investment officer